VECTIBIX

Amgen Canada Inc🇨🇦 Health Canada

Approval Id: 47d061edad7e60ee
Drug Approval Canada Name: VECTIBIX
Product Name: VECTIBIX
Status: Marketed
Status Date: 2017-01-03
Original Market Date: 2017-01-03
Din: 02308509
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 10:00.00
Atc Original: L01FE02 PANITUMUMAB
Atc Name: l 01 fe 02
Aig Number: 0152457001
Company Name: Amgen Canada Inc
Company Address: 300, 6775 Financial Drive, Mississauga, Ontario, Canada, L5N 0A4

PANITUMUMAB

400 MG / 20 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

47d061edad7e60ee

Type

Standard